htbe cells Search Results


90
Lonza primary human tracheobronchial epithelial (htbe) cells
Primary Human Tracheobronchial Epithelial (Htbe) Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human tracheobronchial epithelial (htbe) cells/product/Lonza
Average 90 stars, based on 1 article reviews
primary human tracheobronchial epithelial (htbe) cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Lonza primary human htbe cells
Primary Human Htbe Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary human htbe cells/product/Lonza
Average 90 stars, based on 1 article reviews
primary human htbe cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Lonza commercial primary htbe cells
Commercial Primary Htbe Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/commercial primary htbe cells/product/Lonza
Average 90 stars, based on 1 article reviews
commercial primary htbe cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Cambrex cryopreserved normal human tracheo-bronchial epithelial (htbe) cells
Cryopreserved Normal Human Tracheo Bronchial Epithelial (Htbe) Cells, supplied by Cambrex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cryopreserved normal human tracheo-bronchial epithelial (htbe) cells/product/Cambrex
Average 90 stars, based on 1 article reviews
cryopreserved normal human tracheo-bronchial epithelial (htbe) cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Lonza htbe primary cells
A targeted siRNA screen identifies IAV-required host factors. (A) Schematic representation of the assay used to screen putative host factors for their requirement in influenza virus replication. The green pathway (left) describes the A549 cell-based screen using influenza A/WSN/3 (H1N1) virus and influenza A/Pan/99 (H3N2) virus. The blue pathway (right) describes the follow-up screen performed in primary human tracheal bronchial epithelial <t>(HTBE)</t> cells. (B) Box-and-whisker plots showing the distribution of the raw values from the positive control and the negative control and the experimental data for the A549 cell-based screen (across both IAV subtypes), after the removal of outliers was performed using a Bayesian statistical approach. The first and third quartiles of the remaining data are indicated by the boundaries of the box, with the median indicated within the box. The whiskers represent the extreme boundaries of the data, with extreme values (values exceeding 1.5× the interquartile range beyond the median) plotted as points beyond the whiskers. The window between the positive and negative controls is indicated by a red arrow. (C) The raw data from the A549 cell-based screen were plotted against ideal probability distributions in quantile-quantile (QQ) plots (a graphical method for comparing probability distributions). If data from two distributions are similar, they lie approximately on the line y = x (red). Pearson correlation coefficients measure the degree to which the data fit the proposed probability distribution. The positive control (siRNA targeting influenza virus NP protein) follows a log-normal distribution (R2 = 0.9921), the negative control (nontargeting siRNA) follows a normal distribution (R2 = 0.9922), and the experimental data (siRNAs targeting putative host factors) follow a right-skewed Gumbel distribution (R2 = 0.9941). (D) Example data from an experimental condition are shown to illustrate the hit selection criteria. An siRNA targeting a candidate gene was required to reduce the normalized percentage of infection below 0.6 to be characterized as a hit (shown in green versus nonhits shown in red). Finally, for a gene to be scored as a hit in any screen it was required that at least two siRNAs for a gene candidate met these criteria. (E) The results from the two A549-based screens (purple and green) and the HTBE screen (red) are summarized in a Venn diagram. In the A549 cell-based screen, seven and four genes were uniquely identified in the H1N1 (purple) and H3N2 (green) variants, respectively. A total of 18 genes were identified in both A549 screens. These 18 genes (along with 8 genes from the pilot group) were additionally screened in HTBEs with influenza A/WSN/33 (H1N1) virus. Thirteen genes (brown section) were hits in all three variations of the screen. Gene candidates that were not scored as hits are shown in gray.
Htbe Primary Cells, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/htbe primary cells/product/Lonza
Average 90 stars, based on 1 article reviews
htbe primary cells - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
MatTek differentiated pseudostratified human tracheal–bronchial epithelial cells htbe
A targeted siRNA screen identifies IAV-required host factors. (A) Schematic representation of the assay used to screen putative host factors for their requirement in influenza virus replication. The green pathway (left) describes the A549 cell-based screen using influenza A/WSN/3 (H1N1) virus and influenza A/Pan/99 (H3N2) virus. The blue pathway (right) describes the follow-up screen performed in primary human tracheal bronchial epithelial <t>(HTBE)</t> cells. (B) Box-and-whisker plots showing the distribution of the raw values from the positive control and the negative control and the experimental data for the A549 cell-based screen (across both IAV subtypes), after the removal of outliers was performed using a Bayesian statistical approach. The first and third quartiles of the remaining data are indicated by the boundaries of the box, with the median indicated within the box. The whiskers represent the extreme boundaries of the data, with extreme values (values exceeding 1.5× the interquartile range beyond the median) plotted as points beyond the whiskers. The window between the positive and negative controls is indicated by a red arrow. (C) The raw data from the A549 cell-based screen were plotted against ideal probability distributions in quantile-quantile (QQ) plots (a graphical method for comparing probability distributions). If data from two distributions are similar, they lie approximately on the line y = x (red). Pearson correlation coefficients measure the degree to which the data fit the proposed probability distribution. The positive control (siRNA targeting influenza virus NP protein) follows a log-normal distribution (R2 = 0.9921), the negative control (nontargeting siRNA) follows a normal distribution (R2 = 0.9922), and the experimental data (siRNAs targeting putative host factors) follow a right-skewed Gumbel distribution (R2 = 0.9941). (D) Example data from an experimental condition are shown to illustrate the hit selection criteria. An siRNA targeting a candidate gene was required to reduce the normalized percentage of infection below 0.6 to be characterized as a hit (shown in green versus nonhits shown in red). Finally, for a gene to be scored as a hit in any screen it was required that at least two siRNAs for a gene candidate met these criteria. (E) The results from the two A549-based screens (purple and green) and the HTBE screen (red) are summarized in a Venn diagram. In the A549 cell-based screen, seven and four genes were uniquely identified in the H1N1 (purple) and H3N2 (green) variants, respectively. A total of 18 genes were identified in both A549 screens. These 18 genes (along with 8 genes from the pilot group) were additionally screened in HTBEs with influenza A/WSN/33 (H1N1) virus. Thirteen genes (brown section) were hits in all three variations of the screen. Gene candidates that were not scored as hits are shown in gray.
Differentiated Pseudostratified Human Tracheal–Bronchial Epithelial Cells Htbe, supplied by MatTek, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/differentiated pseudostratified human tracheal–bronchial epithelial cells htbe/product/MatTek
Average 90 stars, based on 1 article reviews
differentiated pseudostratified human tracheal–bronchial epithelial cells htbe - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


A targeted siRNA screen identifies IAV-required host factors. (A) Schematic representation of the assay used to screen putative host factors for their requirement in influenza virus replication. The green pathway (left) describes the A549 cell-based screen using influenza A/WSN/3 (H1N1) virus and influenza A/Pan/99 (H3N2) virus. The blue pathway (right) describes the follow-up screen performed in primary human tracheal bronchial epithelial (HTBE) cells. (B) Box-and-whisker plots showing the distribution of the raw values from the positive control and the negative control and the experimental data for the A549 cell-based screen (across both IAV subtypes), after the removal of outliers was performed using a Bayesian statistical approach. The first and third quartiles of the remaining data are indicated by the boundaries of the box, with the median indicated within the box. The whiskers represent the extreme boundaries of the data, with extreme values (values exceeding 1.5× the interquartile range beyond the median) plotted as points beyond the whiskers. The window between the positive and negative controls is indicated by a red arrow. (C) The raw data from the A549 cell-based screen were plotted against ideal probability distributions in quantile-quantile (QQ) plots (a graphical method for comparing probability distributions). If data from two distributions are similar, they lie approximately on the line y = x (red). Pearson correlation coefficients measure the degree to which the data fit the proposed probability distribution. The positive control (siRNA targeting influenza virus NP protein) follows a log-normal distribution (R2 = 0.9921), the negative control (nontargeting siRNA) follows a normal distribution (R2 = 0.9922), and the experimental data (siRNAs targeting putative host factors) follow a right-skewed Gumbel distribution (R2 = 0.9941). (D) Example data from an experimental condition are shown to illustrate the hit selection criteria. An siRNA targeting a candidate gene was required to reduce the normalized percentage of infection below 0.6 to be characterized as a hit (shown in green versus nonhits shown in red). Finally, for a gene to be scored as a hit in any screen it was required that at least two siRNAs for a gene candidate met these criteria. (E) The results from the two A549-based screens (purple and green) and the HTBE screen (red) are summarized in a Venn diagram. In the A549 cell-based screen, seven and four genes were uniquely identified in the H1N1 (purple) and H3N2 (green) variants, respectively. A total of 18 genes were identified in both A549 screens. These 18 genes (along with 8 genes from the pilot group) were additionally screened in HTBEs with influenza A/WSN/33 (H1N1) virus. Thirteen genes (brown section) were hits in all three variations of the screen. Gene candidates that were not scored as hits are shown in gray.

Journal: mSphere

Article Title: Nucleolar Relocalization of RBM14 by Influenza A Virus NS1 Protein

doi: 10.1128/mSphereDirect.00549-18

Figure Lengend Snippet: A targeted siRNA screen identifies IAV-required host factors. (A) Schematic representation of the assay used to screen putative host factors for their requirement in influenza virus replication. The green pathway (left) describes the A549 cell-based screen using influenza A/WSN/3 (H1N1) virus and influenza A/Pan/99 (H3N2) virus. The blue pathway (right) describes the follow-up screen performed in primary human tracheal bronchial epithelial (HTBE) cells. (B) Box-and-whisker plots showing the distribution of the raw values from the positive control and the negative control and the experimental data for the A549 cell-based screen (across both IAV subtypes), after the removal of outliers was performed using a Bayesian statistical approach. The first and third quartiles of the remaining data are indicated by the boundaries of the box, with the median indicated within the box. The whiskers represent the extreme boundaries of the data, with extreme values (values exceeding 1.5× the interquartile range beyond the median) plotted as points beyond the whiskers. The window between the positive and negative controls is indicated by a red arrow. (C) The raw data from the A549 cell-based screen were plotted against ideal probability distributions in quantile-quantile (QQ) plots (a graphical method for comparing probability distributions). If data from two distributions are similar, they lie approximately on the line y = x (red). Pearson correlation coefficients measure the degree to which the data fit the proposed probability distribution. The positive control (siRNA targeting influenza virus NP protein) follows a log-normal distribution (R2 = 0.9921), the negative control (nontargeting siRNA) follows a normal distribution (R2 = 0.9922), and the experimental data (siRNAs targeting putative host factors) follow a right-skewed Gumbel distribution (R2 = 0.9941). (D) Example data from an experimental condition are shown to illustrate the hit selection criteria. An siRNA targeting a candidate gene was required to reduce the normalized percentage of infection below 0.6 to be characterized as a hit (shown in green versus nonhits shown in red). Finally, for a gene to be scored as a hit in any screen it was required that at least two siRNAs for a gene candidate met these criteria. (E) The results from the two A549-based screens (purple and green) and the HTBE screen (red) are summarized in a Venn diagram. In the A549 cell-based screen, seven and four genes were uniquely identified in the H1N1 (purple) and H3N2 (green) variants, respectively. A total of 18 genes were identified in both A549 screens. These 18 genes (along with 8 genes from the pilot group) were additionally screened in HTBEs with influenza A/WSN/33 (H1N1) virus. Thirteen genes (brown section) were hits in all three variations of the screen. Gene candidates that were not scored as hits are shown in gray.

Article Snippet: HTBE primary cells were obtained from Lonza (donor number 7F3506; catalog no. CC-2541) and were cultured in bronchial epithelial cell growth medium (BEGM) (Lonza; catalog no. CC-3171) supplemented with a BEGM BulletKit (Lonza; catalog no. CC-3170) (complete BEGM), in collagen-coated culture ware, maintaining the cells in the undifferentiated form.

Techniques: Virus, Whisker Assay, Positive Control, Negative Control, Selection, Infection